A Study in Benign Prostatic Hyperplasia

Clinical trial NCT01152190 · COMPLETED

Trial details

NCT number: NCT01152190
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2010-09-01
Primary completion: 2012-07-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.